Ascendis Health Limited
JSE:ASC Lagerbericht
Marktkapitalisierung: R444.3m
Ascendis Health Ausschüttungen und Rückkäufe
Zukünftiges Wachstum Kriterienprüfungen 0/6 Ascendis Health zahlt derzeit keine Dividende.
Wichtige Informationen Gesamte Aktionärsrendite 0% Zukünftige Dividendenrendite n/a Wachstum der Dividende n/a Nächster Dividendenzahlungstermin n/a Ex-Dividendendatum n/a Dividende pro Aktie R0.215 Ausschüttungsquote 0%
Jüngste Updates zu Dividenden und Rückkäufen
Alle Updates anzeigen
Ascendis Health Limited, Annual General Meeting, Nov 29, 2024 Nov 01 An undisclosed buyer acquired an unknown minority stake in Ascendis Health Limited (JSE:ASC) from Alpvest Equities Proprietary Limited. Sep 20
Ascendis Health Limited to Report Fiscal Year 2024 Results on Sep 03, 2024 Aug 30
Ascendis Health Limited to Report First Half, 2024 Results on Mar 28, 2024 Mar 27
Ascendis Health Limited Announces Lawrence Mulaudzi Not Available for Re-Election as Director Nov 30
Ascendis Health Limited, Annual General Meeting, Nov 30, 2023 Nov 01 Ascendis Health To Delist from JSE, Upon Deal Goes Through Sep 29
Ascendis Health Limited Appoints Joseph Fine as Company Secretary Sep 28 Ascendis Health Limited to Report Fiscal Year 2023 Results on Sep 29, 2023
There Is A Reason Ascendis Health Limited's (JSE:ASC) Price Is Undemanding Sep 23
High number of new and inexperienced directors Sep 21
Ascendis Health Limited, Annual General Meeting, Nov 30, 2022 Sep 30
Ascendis Health Limited, Annual General Meeting, Nov 30, 2022 Sep 29
Ascendis Health Limited to Report Fiscal Year 2022 Results on Sep 28, 2022 Sep 27
Ascendis Health Limited Announces Board Changes Jun 14
Ascendis Considers Delisting from JSE Sep 24
Kefolile Health Investments Pty Ltd acquired an unknown minority interest in Ascendis Health Limited (JSE:ASC) Jul 20
MMC International Health Holding S.L entered into sale of shares agreement to acquire Farmalider, S.A. from Ascendis Health Limited (JSE:ASC) for €5 million. Jun 26
The management of Respiratory Care Africa (Pty) Ltd. agreed to acquire Respiratory Care Africa (Pty) Ltd. from Ascendis Health Limited (JSE:ASC) in a management buyout transaction. May 14
First half 2021 earnings released: R0.63 loss per share (vs R0.16 profit in 1H 2020) Apr 02
Independent Non-Executive Director has left the company Mar 15
Ascendis Health Limited Announces Resignation of Yoza Jekwa, with Effect from 11 March 2021 Mar 06
Ascendis Health Limited to Report First Half, 2021 Results on Mar 31, 2021 Feb 18
New 90-day low: R0.66 Feb 15 An unknown buyer acquired an unknown minority stake in Ascendis Health Limited (JSE:ASC) from Public Investment Corporation Limited.
Ascendis Health Limited Approves Board Changes Dec 02
New 90-day high: R0.81 Nov 20
Full year 2020 earnings released: R1.74 loss per share Nov 03
Ascendis Health Limited Announces the Changes to Board Committees Oct 30
New 90-day low: R0.56 Oct 29
Mary Bomela Resigns as Independent Non-Executive Director of Ascendis Health Limited with Effect from 31 October 2020 Oct 15 Ascendis Health Announces the Appointment of Cheryl-Jane (CJ) Kujenga as Chief Financial Officer, Effective 1 December 2020
Ascendis Health Limited Auditor Raises 'Going Concern' Doubt Oct 04
New 90-day low: R0.58 Oct 01
Full year earnings released - R1.74 loss per share Sep 30
Austell Pharmaceuticals Proprietary Limited agreed to acquire Dezzo Trading 392 Proprietary Limited from Ascendis Health Limited (JSE:ASC) for ZAR 80 million. Sep 22
New 90-day low - R0.78 Aug 04 Ascendis Health Limited(JSE:ASC) dropped from S&P Global BMI Index Jun 22
Stabilität und Wachstum des Zahlungsverkehrs
Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von ASC in der Vergangenheit stabil war.
Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von ASC gestiegen sind.
Dividendenrendite im Vergleich zum Markt Ascendis Health Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von ASC im Vergleich zum Markt aus? Segment Dividendenrendite Unternehmen (ASC) 0% Untere 25 % des Marktes (ZA) 3.1% Markt Top 25 % (ZA) 7.9% Branchendurchschnitt (Pharmaceuticals) 2.4% Analystenprognose (ASC) (bis zu 3 Jahre) n/a
Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von ASC im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.
Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von ASC im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: ASC zahlt keine nennenswerte Dividende für den Markt ZA.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da ASC keine Ausschüttungen gemeldet hat.
Entdecken Sie dividendenstarke Unternehmen Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
